Search Medical Condition
Please enter condition
Please choose location

Ormond Beach, Florida Clinical Trials

A listing of Ormond Beach, Florida clinical trials actively recruiting patient volunteers.

RESULTS

Found (111) clinical trials

A Study Comparing the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Chronic Cluster Headache (CCH)

The purpose of the current study is to evaluate the efficacy and safety of TEV-48125 (Fremanezumab), in the prevention of CCH in adult patients.

Phase

0.0 miles

Learn More »

Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia

This study will be conducted to determine the dose response of lemborexant on the change from baseline in actigraphy-derived Sleep Efficiency and Wake Efficiency during the last week of 4 weeks of treatment in participants with Irregular Sleep-Wake Rhythm Disorder and Alzheimer's disease dementia.

Phase

0.0 miles

Learn More »

This study evaluates an investigational oral tablet compared to placebo that may help manage your blood glucose levels.  

Phase

0.0 miles

Learn More »

This study is to evaluate the safety of an existing diabetes drug and how it may help individuals with kidney disease. 

Phase

0.0 miles

Learn More »

To evaluate the safety and efficacy of a once daily oral medication compared to a placebo, in patients with chronic Heart Failure with preserved Ejection Fraction.

Phase

0.0 miles

Learn More »

Type 1 Diabetes study to compare the study injectable medication to Lantus in Type 1 

Phase N/A

0.0 miles

Learn More »

If you have COPD, also known as chronic bronchitis or emphysema, you are likely being treated by a doctor and taking medication for your condition. If you are interested in exploring other options for your COPD, you may want to consider participating in a clinical research study.  

Phase N/A

0.0 miles

Learn More »

Type 2 Diabetes study comparing the study drug to Lantus. 

Phase

0.0 miles

Learn More »

A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

The study uses a randomized, double-blind, placebo-controlled, parallel group, adaptive design with variable treatment duration in approximately 2000 cognitively unimpaired participants aged 60 to 75 years, with at least one APOE4 allele (Homozygotes or Heterozygotes) and, if Heterozygotes, with evidence of elevated brain amyloid. The screening period is expected to ...

Phase

0.0 miles

Learn More »

A Study to Evaluate Safety and Effects of Sotagliflozin Dose 1 and Dose 2 on Glucose Control in Patients With Type 2 Diabetes Severe Impairment of Kidney Function and Inadequate Blood Sugar Control

The study duration is up to 60 weeks including 4 weeks prior to randomization, 52 weeks of randomized treatment and a visit 4 weeks after completion of the randomized treatment period.

Phase

0.0 miles

Learn More »